Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-001497·BlackRock, Inc.
Schedule 13G ownership disclosure
Fate Therapeutics Inc
Common Stock · CUSIP: 31189P102
Event date: 2025-03-31
- Filing-level shares
- 7,852,183
- Percent of class
- 6.9%
- BlackRock, Inc.
Shares: 7,852,183 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001497
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Apr 23, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership